tiprankstipranks
Guorui Properties Ltd (HK:2329)
:2329
Want to see HK:2329 full AI Analyst Report?

Guorui Properties Ltd (2329) AI Stock Analysis

0 Followers

Top Page

HK:2329

Guorui Properties Ltd

(2329)

Select Model
Select Model
Select Model
Neutral 42 (OpenAI - 5.2)
Rating:42Neutral
Price Target:
HK$0.08
▼(-40.00% Downside)
Action:Reiterated
Date:05/07/26
The score is held down primarily by weak financial performance (sharp profitability deterioration, high and rising leverage, and a major 2025 cash flow contraction). Technicals add further pressure with price below major moving averages and a negative MACD, while valuation provides limited support due to a negative P/E and no dividend yield data.
Positive Factors
Positive Equity Cushion
Reportedly positive shareholders' equity indicates the firm is not balance-sheet insolvent; that cushion supports refinancing options and creditor negotiations over the next several months, reducing immediate bankruptcy risk and preserving capacity to pursue asset disposals or restructuring if needed.
Negative Factors
Sharp Profitability Deterioration
A sudden revenue collapse and deeply negative margins signify operating model stress: pricing, cost or project impairments. Persistently negative margins undermine internal financing, erode equity, and make recovery dependent on substantial operational improvements or asset sales over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Positive Equity Cushion
Reportedly positive shareholders' equity indicates the firm is not balance-sheet insolvent; that cushion supports refinancing options and creditor negotiations over the next several months, reducing immediate bankruptcy risk and preserving capacity to pursue asset disposals or restructuring if needed.
Read all positive factors

Guorui Properties Ltd (2329) vs. iShares MSCI Hong Kong ETF (EWH)

Guorui Properties Ltd Business Overview & Revenue Model

Company Description
Glory Health Industry Limited functions as an investment holding company, concentrating its efforts on real estate development within the People's Republic of China. The firm's activities are organized into four principal divisions: Property Devel...
How the Company Makes Money
Guorui Properties Ltd primarily makes money by developing real estate projects and selling completed properties to end buyers, recognizing revenue from contracted sales/handovers in accordance with applicable accounting standards. Additional reven...

Guorui Properties Ltd Financial Statement Overview

Summary
Financial condition is weak based on the provided statement scores and notes: profitability deteriorated sharply with revenue down ~50% in 2025 and margins deeply negative, leverage is high and rising (debt-to-equity ~2.94x), and operating/free cash flow collapsed in 2025, increasing liquidity and refinancing risk.
Income Statement
12
Very Negative
Balance Sheet
28
Negative
Cash Flow
22
Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.04B2.71B2.51B3.90B9.90B
Gross Profit-308.09M555.56M-50.28M113.52M1.25B
EBITDA-696.90M295.14M-145.86M-325.93M581.55M
Net Income-1.82B-1.24B-563.97M-912.78M228.33M
Balance Sheet
Total Assets56.70B57.20B56.35B57.39B61.07B
Cash, Cash Equivalents and Short-Term Investments138.18M158.10M152.22M189.51M556.87M
Total Debt23.83B22.79B22.18B21.25B20.95B
Total Liabilities46.10B44.83B42.57B43.01B45.64B
Stockholders Equity8.11B9.93B11.17B11.73B12.71B
Cash Flow
Free Cash Flow15.19M678.26M452.11M413.47M4.07B
Operating Cash Flow36.24M679.53M512.92M606.31M4.35B
Investing Cash Flow-861.82M146.72M58.95M-305.41M184.15M
Financing Cash Flow777.99M-830.50M-627.40M-630.90M-5.65B

Guorui Properties Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.14
Price Trends
50DMA
0.10
Negative
100DMA
0.11
Negative
200DMA
0.12
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
48.02
Neutral
STOCH
55.91
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2329, the sentiment is Negative. The current price of 0.14 is above the 20-day moving average (MA) of 0.09, above the 50-day MA of 0.10, and above the 200-day MA of 0.12, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 48.02 is Neutral, neither overbought nor oversold. The STOCH value of 55.91 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2329.

Guorui Properties Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
56
Neutral
HK$651.66M8.041.64%6.71%15.45%67.35%
51
Neutral
HK$501.60M-0.53-44.38%11.33%6.38%
42
Neutral
HK$408.89M-0.19-13.99%-62.05%-47.92%
41
Neutral
HK$369.45M-0.037.94%-10.86%
40
Underperform
HK$339.06M-0.13-35.32%-2.03%-59.52%
39
Underperform
HK$355.31M-0.09-55.49%-38.93%59.60%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2329
Guorui Properties Ltd
0.09
-0.07
-42.14%
HK:1813
KWG Group Holdings
0.10
-0.21
-66.45%
HK:1777
Fantasia Holdings Group Co. Ltd.
0.06
>-0.01
-7.25%
HK:1243
Wang On Properties Ltd.
0.03
<0.01
3.13%
HK:1278
China New Town Development Co. Ltd.
0.07
-0.06
-46.40%
HK:3688
Top Spring International Holdings Limited
0.24
-0.09
-27.27%

Guorui Properties Ltd Corporate Events

Glory Health Industry Wins Shareholder Backing for Governance and Capital Mandates at AGM
Jun 30, 2026
Glory Health Industry Limited, incorporated in the Cayman Islands and listed on the Hong Kong Stock Exchange, operates in the health industry through a group of subsidiaries consolidated in its financial reporting. The company is overseen by a boa...
Glory Health Industry Sets AGM to Approve Results, Board Mandates and New Share Issue Authority
Jun 8, 2026
Glory Health Industry Limited has called its annual general meeting for June 30, 2026, in Beijing to review the audited consolidated financial statements for the year ended December 31, 2025, and to receive the reports of its directors and auditor...
Glory Health Industry Sets Out Board and Committee Structure
Jun 2, 2026
Glory Health Industry Ltd has published an updated list of its board of directors, naming five executive directors, including chairman Zhang Zhangsun, and three independent non-executive directors. The disclosure also sets out the composition and ...
Glory Health Industry Tightens Governance With Revised Nomination Committee Charter
Jun 2, 2026
Glory Health Industry Limited has revised and approved a new charter for its Nomination Committee, aimed at regulating director appointments, optimizing board composition and strengthening its corporate governance structure in line with Hong Kong ...
Glory Health Industry Moves to Update Articles in Line With New HK Listing Rules
May 26, 2026
Glory Health Industry Limited plans to overhaul its constitutional documents by adopting a third amended and restated articles of association, replacing the current version. The move is aimed at aligning the company&#8217;s governance framework wi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 07, 2026